1. Home
  2. ARDX vs TILE Comparison

ARDX vs TILE Comparison

Compare ARDX & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • TILE
  • Stock Information
  • Founded
  • ARDX 2007
  • TILE 1973
  • Country
  • ARDX United States
  • TILE United States
  • Employees
  • ARDX N/A
  • TILE N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • TILE Home Furnishings
  • Sector
  • ARDX Health Care
  • TILE Consumer Discretionary
  • Exchange
  • ARDX Nasdaq
  • TILE Nasdaq
  • Market Cap
  • ARDX 1.3B
  • TILE 1.1B
  • IPO Year
  • ARDX 2014
  • TILE N/A
  • Fundamental
  • Price
  • ARDX $4.79
  • TILE $19.87
  • Analyst Decision
  • ARDX Strong Buy
  • TILE Buy
  • Analyst Count
  • ARDX 9
  • TILE 1
  • Target Price
  • ARDX $10.61
  • TILE $30.00
  • AVG Volume (30 Days)
  • ARDX 3.9M
  • TILE 654.1K
  • Earning Date
  • ARDX 05-01-2025
  • TILE 05-02-2025
  • Dividend Yield
  • ARDX N/A
  • TILE 0.21%
  • EPS Growth
  • ARDX N/A
  • TILE 94.74
  • EPS
  • ARDX N/A
  • TILE 1.48
  • Revenue
  • ARDX $333,615,000.00
  • TILE $1,315,658,000.00
  • Revenue This Year
  • ARDX $14.26
  • TILE $4.74
  • Revenue Next Year
  • ARDX $32.49
  • TILE $5.30
  • P/E Ratio
  • ARDX N/A
  • TILE $13.41
  • Revenue Growth
  • ARDX 168.06
  • TILE 4.29
  • 52 Week Low
  • ARDX $4.32
  • TILE $14.13
  • 52 Week High
  • ARDX $9.33
  • TILE $27.34
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 37.46
  • TILE 46.51
  • Support Level
  • ARDX $4.68
  • TILE $19.31
  • Resistance Level
  • ARDX $5.56
  • TILE $20.48
  • Average True Range (ATR)
  • ARDX 0.25
  • TILE 0.61
  • MACD
  • ARDX -0.05
  • TILE 0.20
  • Stochastic Oscillator
  • ARDX 12.71
  • TILE 72.61

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.

Share on Social Networks: